News
13h
MedPage Today on MSNGLP-1 Med Users See Drop in Recurrent Afib EventsAccounting for mortality as competing risk, the Afib burden trended numerically in favor of the GLP-1 RA group (HR 0.85, 95% ...
Experts express alarm that GLP-1 RAs may trigger or worsen eating disorders. But is there any role they might play in binge ...
As the FDA cracks down on compounded GLP-1 drugs like semaglutide and tirzepatide, the market for GLP-1 supplements is taking ...
Some experts say oral versions of popular weight-loss drugs such as Wegovy could offer people more flexibility and ...
Pharmaceutical giant Eli Lilly alleges the companies are selling illegal off-brand versions of its best-selling diabetes and ...
Spending on Ozempic, Wegovy and other similar prescriptions soared 500 percent in five years, according to a research letter.
GLP-1 medications like Ozempic may help reduce alcohol cravings and support recovery—especially when combined with therapy ...
A large group of teenagers on bikes were caught on cellphone cameras looting a Ralphs, releasing pepper spray in the Los ...
Let's look at why this news could be a game-changer for Eli Lilly and its stock.
While some Americans might feel doubtful about prescriptions, others are doing all they can to acquire GLP-1 drugs. Carly ...
Menopause and the natural phenomenon of weight gain in middle age make this a topic for primary care physicians to watch.
GLP-1 receptor agonists are effective weight-loss medications, but they may also decrease muscle mass, raising concerns about ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results